Paid by 14:30 Mon–Fri → dispatched today · Free UK tracked delivery on £150+

For laboratory research use only. Not for human or veterinary use. Not a medicine, food supplement or cosmetic.

Your basket

Your basket is empty.

Browse peptides
GH Secretagogues & GHRH Analogues

Modified GRF (1-29)

Also known as CJC-1295 without DAC · Mod GRF 1-29 · CJC-1295 no DAC · CJC-1295 w/o DAC

Choose size and grade
What is Reserve Grade?

Reserve Grade batches pass extra endotoxin and heavy-metal testing on top of the standard HPLC purity analysis. Results are on each batch certificate.

Price includes UK VAT · SKU MODGRF-2mg

  • Paid by 14:30 Mon–Fri: dispatched the same day
  • Free Royal Mail Tracked 24 on UK orders of £150 or more
  • Plain, discreet packaging

Research use only. Not for human or veterinary use. Not a medicine, food supplement or cosmetic.

WADA notice. This compound is on the World Anti-Doping Agency Prohibited List. It is supplied for laboratory research and must not be used in sport.

Current batch

SKUBatchResultDateReport
MODGRF-5mgP180925-LR63828498.75% purity (HPLC-MS)25 Sept 2018 (lot date)
Manufacturer's QC laboratory
PDF
PREM-MODGRF-5mgP180925-LR63828498.75% purity (HPLC-MS)25 Sept 2018 (lot date)
Manufacturer's QC laboratory
PDF
PREM-MODGRF-2mgP191102-23-LR63828498.61% purity (HPLC-MS)2 Nov 2019 (lot date)
Manufacturer's QC laboratory
PDF

Manufacturer batch report: HPLC purity (and mass spectrometry where stated), as supplied with the lot.

Overview

Modified GRF (1-29) 2mg (CJC-1295 without DAC)

Overview

Modified GRF (1-29), also known as CJC-1295 without DAC, is a synthetic peptide derived from the growth hormone-releasing hormone (GHRH) sequence. Designed to stimulate the endogenous release of growth hormone (GH) from the pituitary gland, this peptide has become a focus of scientific research in areas such as GH pulsatility, lipid metabolism, cellular repair, and age-related physiological decline.

Unlike its DAC-conjugated counterpart, Modified GRF (1-29) does not contain the Drug Affinity Complex (DAC), resulting in a shorter biological half-life but a more natural pulsatile GH release pattern that mimics the body’s physiological secretion rhythm.


Research Background

Growth hormone (GH) plays a critical role in metabolism, cell regeneration, and body composition. Researchers have long sought methods to regulate its secretion safely and effectively. Modified GRF (1-29) is a tetrasubstituted GHRH analogue engineered to be more stable than the native peptide, yet without DAC to preserve short, natural signalling pulses.

This configuration is of particular interest in studies exploring endocrine modulation, tissue recovery, and age-related GH decline, as it avoids receptor desensitisation often associated with continuous GH exposure.


Mechanism of Action

Modified GRF (1-29) binds to GHRH receptors in the anterior pituitary, initiating a cascade that promotes the release of endogenous growth hormone. Research suggests that this process results in pulsatile GH secretion, closely mirroring physiological secretion patterns.

By enhancing GH output rather than replacing it exogenously, Modified GRF (1-29) allows for regulated, receptor-sensitive release. This mechanism differentiates it from other compounds that sustain unnaturally prolonged GH levels.


Research Focus Areas of Interest

  1. Skeletal Muscle Biology Growth hormone has a known role in protein synthesis and tissue repair. Modified GRF (1-29) has been studied in models of GH-mediated anabolic signalling and muscle regeneration.

  2. Lipid Metabolism GH has established lipolytic effects. Research into Modified GRF (1-29) examines GH-mediated lipolysis and substrate utilisation in metabolic models.

  3. Cellular Repair and Regeneration Scientific interest includes the peptide’s indirect role in cellular renewal and tissue maintenance, aligning with GH’s established physiological pathways.

  4. Age-Related Endocrine Function As natural GH levels decline with age, Modified GRF (1-29) is being studied for its capacity to modulate age-associated changes in growth hormone secretion, offering a model for understanding age-related endocrine decline.

Technical Details

  • Synonyms: Mod-GRF (1-29), Modified GRF (1-29), CJC-1295 without DAC
  • Sequence: YADAIFTNSYRKVLGQLSARKLLQDIMSR
  • IUPAC Condensed: H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂
  • Molecular Weight: 3367.95 g/mol
  • CAS Number: 863288-34-0
  • PubChem CID: 91976842
  • Further References: PubChem

Stability and Storage

Store lyophilised protein at –20 °C. Aliquot after reconstitution to avoid repeated freezing/thawing cycles. Once reconstituted, the solution may be stored at 4 °C for a limited period. The lyophilised peptide remains stable until the expiry date when stored correctly at –20 °C.


Source and Reconstitution

Source: Biosynthesis Reconstitution: Reconstitute with Bacteriostatic Water


Usage

This product is prepared for laboratory research only. Modified GRF (1-29) for sale at Premium Peptides UK is intended exclusively for scientific and educational use. Only purchase Modified GRF (1-29) if you are a licensed researcher.

Research kits with Modified GRF (1-29)

Reconstitution supplies